Skip to main content
Clinical Trials/CTRI/2021/03/031963
CTRI/2021/03/031963
Not yet recruiting
Phase 4

Comparative evaluation of efficacy and safety of combination of microneedling with topical autologous Platelet rich plasma versus Triamcinolone acetonide in Alopecia Areata

Dr Surabhi Dayal0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Surabhi Dayal
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Surabhi Dayal

Eligibility Criteria

Inclusion Criteria

  • Clinically diagnosed as Alopecia Areata of the scalp less than or equal to 5 patches and less than or equal to 25 % scalp involvement and who have not taken any treatment for hair loss in the past 3 months and are willing to consent for enrollment in the study

Exclusion Criteria

  • Patients with history of bleeding disorders,on anticoagulant medications,with an active infection at local site,having keloidal tendency, having psoriasis or lichen planus because of risk of Koebner phenomenon or any other dermatological disease,having alopecia totalis or alopecia universalis,who had taken any treatment for hair\-loss in the past 3 months,with history of hypersensitivity to formulation used in the study,Severe systemic illness or malignancy,Pregnant and lactating mothers.

Outcomes

Primary Outcomes

Not specified

Similar Trials